Amy Jia Wang, MPH, MSc

Amy Jia Wang, MPH, MSc has a diverse work experience spanning across various industries. Amy Jia currently holds the position of VP, Head of Business Development and Alliance Management at Vera Therapeutics, Inc. since February 2023. Prior to this, they worked as a Senior Director and the Head of Business Development at the same company from July 2022 to February 2023.

Before joining Vera Therapeutics, Amy worked at Horizon, where they held the role of Director, External Innovation (Search & Evaluation) from February 2020 to July 2022. Amy Jia also served as the Director of Business Development & Transactions from February 2018 to January 2020.

Amy has also gained invaluable experience in the financial industry, as they worked at JMP Securities LLC as a Biotech Equity Research Associate. Amy Jia'srole involved equity research coverage of various biotech companies, with a specific focus on rare diseases. Amy Jia conducted financial modeling, interviews with industry professionals, and evaluated the scientific, clinical, and commercial merit of pipeline assets and marketed products to develop investment strategies. Amy held this position from November 2016 to February 2018.

Additionally, Amy worked as a Senior Associate at Deallus, a life science specialized consulting firm. Amy Jia'srole focused on providing market insights and support for brand, franchise, and corporate management in the biopharmaceutical industry. Amy Jia worked with a global team of consultants with expertise in clinical-scientific and commercial aspects. Amy was associated with Deallus from July 2014 to October 2016.

Amy's work experience also includes a role at Yale New Haven Hospital, where they were involved in supply chain management. During their time there, they worked on supplier management, contract negotiations, analytics, and material management. Amy Jia developed Supply Chain College material to educate internal customers about the role and function of supply chain management. Amy worked at Yale New Haven Hospital from January 2014 to May 2014.

Amy has also gained experience in the regulatory affairs field through their work at Bayer HealthCare, where they conducted an independent consulting project for the Global Regulatory Affairs division. Amy Jia analyzed policy initiatives, benefit-risk assessments, and provided recommendations for the drug development process. Amy also contributed to the gynecological drug marketing authorization strategy and participated in FDA Advisory Committee meetings. Amy Jia was associated with Bayer HealthCare from June 2013 to August 2013.

Furthermore, Amy worked as a Marketing Consultant at Covidien (Medtronic Minimally Invasive Therapies Group) for a brief period from February 2013 to May 2013.

Amy's earlier work experience includes positions at Easton Associates (acquired by Navigant Consulting) as a Research Associate from January 2012 to April 2012, as well as DM Capital Ltd, where they served as a Healthcare Investment Manager for a short period from July 2011 to August 2011.

Amy's career started at the U Washington School of Medicine, where they worked as a Research Assistant from September 2008 to March 2010.

Overall, Amy Jia Wang, MPH, MSc has a wealth of experience in business development, equity research, consulting, supply chain management, regulatory affairs, and research.

Amy Jia Wang, MPH, MSc has a diverse education history. Amy Jia holds certificates in Negotiation Mastery, Leadership Principles, Disruptive Strategy, and Business Law from Harvard Business School Executive Education. Amy Jia obtained a Master of Public Health (MPH) degree in Health Care Management from Yale University. Amy is currently a PhD Candidate in Biochemistry and Neuroscience at Cornell University. Amy Jia has also studied as an Exchange Scholar at the University of Washington, focusing on Biomedical Science, Stem Cell, and Regenerative Medicine. Amy completed their undergraduate education at Sichuan University, where they earned a Bachelor of Science (B.S) degree in Biotechnology.